CYCC Bio Green Med Solution Inc.


$ 1.39 $ 0.20 (16.81 %)    

Tuesday, 18-Nov-2025 13:52:36 EST
QQQ $ 599.52 $ -0.10 (-0.02 %)
DIA $ 462.87 $ 0.71 (0.15 %)
SPY $ 663.12 $ 0.99 (0.15 %)
TLT $ 88.93 $ -0.42 (-0.47 %)
GLD $ 374.71 $ -0.18 (-0.05 %)
$ 1.21
$ 1.19
$ 1.34 x 100
$ 1.39 x 500
$ 1.23 - $ 1.61
$ 1.21 - $ 101.30
43,545
na
na
$ 1.29
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION